Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $840,212 (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 27.9%

Value ($000) $234,246 Shares 8,964,640 Est. Cost $21.05 Unrealized +13.7%

IRWD IRONWOOD PHARMACEUTICALS INC 24.2%

Value ($000) $203,072 Shares 16,390,000 Est. Cost $11.52 Unrealized -1.5%

BIIB BIOGEN INC 21.2%

Value ($000) $178,060 Shares 643,000 Est. Cost $278.12 Unrealized +1.6%

GILD GILEAD SCIENCES INC 10.9%

Value ($000) $91,752 Shares 1,068,750 Est. Cost $53.90 Unrealized +31.3%

INVA INNOVIVA INC 10.4%

Value ($000) $87,636 Shares 6,614,000 Est. Cost $13.07 Unrealized +0.6%

— MERSANA THERAPEUTICS INC 2.8%

Value ($000) $23,422 Shares 3,997,010 Est. Cost $9.56 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 1.3%

Value ($000) $11,254 Shares 980,288 Est. Cost $4.84 Unrealized +157.6%

— AMARIN CORP PLC 0.7%

Value ($000) $5,816 Shares 4,807,000 Est. Cost $3.97 Unrealized —

— VOR BIOPHARMA INC 0.5%

Value ($000) $4,110 Shares 618,000 Est. Cost $43.10 Unrealized —

— PEAR THERAPEUTICS INC 0.1%

Value ($000) $590 Shares 500,356 Est. Cost $6.20 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value ($000) $254 Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	8,964,640	$234,246	27.9%	$21.05	+13.7%	SHS	G01767105
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$203,072	24.2%	$11.52	-1.5%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$178,060	21.2%	$278.12	+1.6%	COM	09062X103
GILD	GILEAD SCIENCES INC	1,068,750	$91,752	10.9%	$53.90	+31.3%	COM	375558103
INVA	INNOVIVA INC	6,614,000	$87,636	10.4%	$13.07	+0.6%	COM	45781M101
—	MERSANA THERAPEUTICS INC	3,997,010	$23,422	2.8%	$9.56	—	COM	59045L106
BCRX	BIOCRYST PHARMACEUTICALS INC	980,288	$11,254	1.3%	$4.84	+157.6%	COM	09058V103
—	AMARIN CORP PLC	4,807,000	$5,816	0.7%	$3.97	—	SPONS ADR NEW	023111206
—	VOR BIOPHARMA INC	618,000	$4,110	0.5%	$43.10	—	COM	929033108
—	PEAR THERAPEUTICS INC	500,356	$590	0.1%	$6.20	—	CLASS A COM	704723105
—	REGULUS THERAPEUTICS INC	185,183	$254	0.0%	$2.07	—	COM	75915K309